title: Safe and effective treatment for patients with isoniazid drug resistance.
authors: MRC Clinical Trials Unit, University College, London, UK. patrick.phillips@ucl.ac.uk.
authors: P P J
authors: PP
authors: Phillips
authors: Department of HIV Medicine, Royal Free London NHS Foundation Trust, University College London, London, UK.
authors: M C
authors: MC
authors: Lipman
mesh_terms: D000995:Antitubercular Agents / Q000008:administration & dosage* / Q000009:adverse effects*; D024881:Drug Resistance, Bacterial; D004977:Ethambutol / Q000008:administration & dosage*; D005260:Female; D006801:Humans; D007538:Isoniazid / Q000009:adverse effects*; D008297:Male; D011718:Pyrazinamide / Q000008:administration & dosage*; D012293:Rifampin / Q000008:administration & dosage*; D014376:Tuberculosis / Q000188:drug therapy*
chemical_list: D000995:Antitubercular Agents; D011718:Pyrazinamide; D004977:Ethambutol; D007538:Isoniazid; D012293:Rifampin